The contribute of cerebrospinal fluid free light-chain assay in the diagnosis of multiple sclerosis and other neurological diseases in an Italian multicenter study

1. Castelli, L, Comi, C, Chiocchetti, A, et al. ICOS gene haplotypes correlate with IL10 secretion and multiple sclerosis evolution. J Neuroimmunol 2007; 186(1–2): 193–198.
Google Scholar | Crossref | Medline2. Greenfield, AL, Hauser, SL. B-cell therapy for multiple sclerosis: Entering an era. Ann Neurol 2018; 83(1): 13–26.
Google Scholar | Crossref | Medline3. Tatomir, A, Talpos-Caia, A, Anselmo, F, et al. The complement system as a biomarker of disease activity and response to treatment in multiple sclerosis. Immunol Res 2017; 65(6): 1103–1109.
Google Scholar | Crossref | Medline4. Hemmer, B, Nessler, S, Zhou, D, et al. Immunopathogenesis and immunotherapy of multiple sclerosis. Nat Clin Pract Neurol 2006; 2: 201–211.
Google Scholar | Crossref | Medline5. Gastaldi, M, Zardini, E, Franciotta, D. An update on the use of cerebrospinal fluid analysis as a diagnostic tool in multiple sclerosis. Expert Rev Mol Diagn 2017; 17(1): 31–46.
Google Scholar | Crossref | Medline6. Thompson, AJ, Banwell, BL, Barkhof, F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018; 17: 162–173.
Google Scholar | Crossref | Medline | ISI7. Petzold, A . Intrathecal oligoclonal IgG synthesis in multiple sclerosis. J Neuroimmunol 2013; 262(1–2): 1–10.
Google Scholar | Crossref | Medline8. Berek, K, Hegen, H, Auer, M, et al. Cerebrospinal fluid oligoclonal bands in neuroborreliosis are specific for Borrelia burgdorferi. PLoS ONE 2020; 15(9): e0239453.
Google Scholar | Medline9. Haertle, M, Kallweit, U, Weller, M, et al. The presence of oligoclonal IgG bands in human CSF during the course of neurological diseases. J Neurol 2014; 261(3): 554–560.
Google Scholar | Crossref | Medline10. Mayringer, I, Timeltaler, B, Deisenhammer, F. Correlation between the IgG index, oligoclonal bands in CSF, and the diagnosis of demyelinating diseases. Eur J Neurol 2005; 12(7): 527–530.
Google Scholar | Crossref | Medline11. Kaplan, B, Aizenbud, BM, Golderman, S, et al. Free light chain monomers in the diagnosis of multiple sclerosis. J Neuroimm 2010; 229: 263–271.
Google Scholar | Crossref | Medline | ISI12. Presslauer, S, Milosavljevic, D, Brücke, T, et al. Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis [published correction appears in J Neurol. 2009; 256(12): 2115. Hübl, Walter [corrected to Hübl, Wolfgang]]. J Neurol 2008; 255(10): 1508–1514.
Google Scholar | Crossref | Medline13. Crespi, I, Sulas, MG, Mora, R, et al. Combined use of kappa free light chain index and isoelectrofocusing of cerebro-spinal fluid in diagnosing multiple sclerosis: Performances and costs. Clin Lab 2017; 63: 551–559.
Google Scholar | Crossref | Medline14. Arneth, B, Birklein, F. High sensitivity of free lambda and free kappa light chains for detection of intrathecal immunoglobulin synthesis in cerebrospinal fluid. Acta Neurol Scand 2009; 119(1): 39–44.
Google Scholar | Crossref | Medline15. Fischer, C, Arneth, B, Koehler, J, et al. Kappa free light chains in cerebrospinal fluid as markers of intrathecal immunoglobulin synthesis. Clin Chem 2004; 50: 1809–1813.
Google Scholar | Crossref | Medline | ISI16. Reiber, H, Peter, JB. Cerebrospinal fluid analysis: Disease-related data patterns and evaluation programs. J Neurol Sci 2001; 184: 101–122.
Google Scholar | Crossref | Medline | ISI17. Ferraro, D, Bedin, R, Natali, P, et al. Kappa index versus CSF oligoclonal bands in predicting multiple sclerosis and infectious/inflammatory CNS disorders. Diagnostics 2020; 10(10): 856.
Google Scholar | Crossref18. Crespi, I, Vecchio, D, Serino, R, et al. K index is a reliable marker of intrathecal synthesis, and an alternative to IgG index in multiple sclerosis diagnostic work-up. J Clin Med 2019; 8(4): 446.
Google Scholar | Crossref19. Leurs, CE, Twaalfhoven, H, Lissenberg-Witte, BI, et al. Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study. Mult Scler 2020; 26(8): 912–923.
Google Scholar | SAGE Journals | ISI20. Pieri, M, Storto, M, Pignalosa, S, et al. KFLC index utility in multiple sclerosis diagnosis: Further confirmation. J Neuroimmunol 2017; 309: 31–33.
Google Scholar | Crossref | Medline21. Teunissen, C, Menge, T, Altintas, A, et al. Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis. Mult Scler 2013; 19(13): 1802–1809.
Google Scholar | SAGE Journals | ISI22. Ferraro, D, Trovati, A, Bedin, R, et al. Cerebrospinal fluid kappa and lambda free light chains in oligoclonal band-negative patients with suspected multiple sclerosis. Eur J Neurol 2019; 27(3): 461–467.
Google Scholar | Crossref | Medline23. Jarius, S, Eichhorn, P, Wildemann, B, et al. Usefulness of antibody index assessment in cerebrospinal fluid from patients negative for total-IgG oligoclonal bands. Fluids Barriers CNS 2012; 9(1): 14.
Google Scholar | Crossref | Medline24. Villar, LM, Espiño, M, Costa-Frossard, L, et al. High levels of cerebrospinal fluid free kappa chains predict conversion to multiple sclerosis. Clin Chim Acta 2012; 413(23–24): 1813–1816.
Google Scholar | Crossref | Medline25. Mariotto, S, Ferraro, D, Soldani, F, et al. Inter-center agreement in the interpretation of oligoclonal bands. Clin Chem Lab Med 2020; 59(3): e91–e94.
Google Scholar | Crossref | Medline26. Zeman, D, Hradilek, P, Kusnierova, P, et al. Oligoclonal free light chains in cerebrospinal fluid as markers of intrathecal inflammation. Comparison with oligoclonal IgG. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2015; 159(1): 104–113.
Google Scholar | Crossref | Medline27. Cavalla, P, Caropreso, P, Limoncelli, S, et al. Kappa free light chains index in the differential diagnosis of multiple sclerosis from neuromyelitis optica spectrum disorders and other immune-mediated central nervous system disorders. J Neuroimmunol 2020; 339: 577122.
Google Scholar | Crossref | Medline28. Süße, M, Hannich, M, Petersmann, A, et al. Kappa free light chains in cerebrospinal fluid to identify patients with oligoclonal bands. Eur J Neurol 2018; 25(9): 1134–1139.
Google Scholar | Crossref | Medline29. Tjernberg, I, Johansson, M, Henningsson, AJ. Diagnostic performance of cerebrospinal fluid free light chains in Lyme neuroborreliosis—A pilot study. Clin Chem Lab Med 2019; 57(12): 2008–2018.
Google Scholar | Crossref | Medline30. Hegen, H, Milosavljevic, D, Schnabl, C, et al. Cerebrospinal fluid free light chains as diagnostic biomarker in neuroborreliosis. Clin Chem Lab Med 2018; 56(8): 1383–1391.
Google Scholar | Crossref | Medline31. Agnello, L, Lo Sasso, B, Salemi, G, et al. Clinical use of κ free light chains index as a screening test for multiple sclerosis. Lab Med 2020; 51(4): 402–407.
Google Scholar | Crossref | Medline32. Gaetani, L, Di Carlo, M, Brachelente, G, et al. Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis. J Neuroimmunol 2020; 339: 577108.
Google Scholar | Crossref | Medline33. Puthenparampil, M, Altinier, S, Stropparo, E, et al. Intrathecal K free light chain synthesis in multiple sclerosis at clinical onset associates with local IgG production and improves the diagnostic value of cerebrospinal fluid examination. Mult Scler Relat Disord 2018; 25: 241–245.
Google Scholar | Crossref | Medline34. Tusseau, M, Cheli, E, Marignier, R, et al. Clinical significance of a single cerebrospinal fluid immunoglobulin band: A retrospective study. Mult Scler 2021; 27(9): 1451–1454.
Google Scholar | SAGE Journals

留言 (0)

沒有登入
gif